1. Pappas G, Papadimitriou P, Christou L, Akritidis N. Future trends in human brucellosis treatment. Expert Opin Investig Drugs 2006; 15: 1141–1149.
2. Al Dahouk S, Flèche PL, Noeckler K, Jacques I, Grayon M, Scholz HC, et al. Evaluation of Brucella MLVA typing for human brucellosis. J Microbool Methods 2007; 69:137–145.
3. Amirmozafari N, Ghazi F, Mostafazadeh A, Mostafaie A, Rajabnia R. Comparison of heat shock response in Brucella obortus and Brucella melitensis. Pak J Biol Sci 2008; 11:188-194.
4. Berzofsky JA. Intrinsic and extrinsic factors in protein antigenic structure. Science 1985; 229:932–940.
5. Buus S, Lauemøller SL, Worning P, Kesmir C, Frimurer T, Corbet S, et al. Sensitive quantitative predictions of peptide-MHC binding by a 'Query by Committee' artificial neural network approach. Tissue Antigens 2003; 62:378-384.
6. Zhang W, Liu J, Zhao M, Li Q. Predicting linear B-cell epitopes by using sequence-derived structural and physicochemical features. Int J Data Min Bioinform 2012; 6:557-569.
7. Ponomarenko JV, van Regenmortel MHV. B-cell epitope prediction. Second Ed. Structural Bioinformatics; 2009.
8. Chen P, Rayner S, Hu KH. Advances of bioinformatics tools applied in virus epitopes prediction. Virol Sin 2011; 26:1-7.
9. Steere AC, Drouin EE, Glickstein LJ. Relationship between immunity to Borrelia burgdorferi outer-surface protein A (OspA) and Lyme arthritis. Clin Infect Dis 2011; 52:259–265.
10. Hopp TP, Woods KR. Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci USA 1981; 78:3824–3828.
11. Donnes P, Elofsson A. Prediction of MHC class I binding peptides, using SVMHC. BMC Bioinformatics 2002; 3:25.
12. Noguchi H, Kato R, Hanai T, Matsubara Y, Honda H, Brusic V, et al. Hidden Markov model-based prediction of antigenic peptides that interact with MHC class II molecules. J Biosci Bioeng 2002; 94:264-270.
13. Delpino MV, Estein SM, Fossati CA, Baldi PC, Cassataro J. Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice. Vaccine2007; 25:6721-6729.
14. Sambrook JF, Russell DW. Molecular Cloning: A Laboratory Manual. 3rd ed. NY: Cold Spring Harbor Laboratory, Cold Spring Harbor; 2001.
15. Geourjon C, Deléage G. SOPMA: significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments. Comput Appl Biosci 1995; 11:681-684.
16. Wass MN, Sternberg MJ. Prediction of ligand binding sites using homologous structures and conservation at CASP8. Proteins 2009; 77:147-151.
17. Simon GG , Hu Y, Khan AM, Zhou J, Salmon J, Chikhlikar PR, et al. Dendritic cell mediated delivery of plasmid DNA encoding LAMP/HIV-1 Gag fusion immunogen enhances T cell epitope responses in HLA DR4 transgenic mice. PLoS One 2010; 5:e8574.
18. Tabatabai LB, Pugh GW Jr. Modulation of immune responses in Balb/c mice vaccinated with Brucella abortus Cu-Zn superoxide dismutase synthetic peptide vaccine. Vaccine 1995; 12:919-924.
19. Toes RE, Nussbaum AK, Degermann S, Schirle M, Emmerich NP, Kraft M, et al. Discrete cleavage motifsconstitutive and immunoproteasomes revealed by quantitative analysis of cleavage products. J Exp Med 2001; 194:1-12.
20. Vizcaíno N, Zygmunt MS, Verger JM, Grayon M, Cloeckaert A. Localization and characterization of a specific linear epitope of the Brucella DnaK protein. FEMS Microbiol Lett 1997; 154:117-122.
21. Li Y, Liu X, Zhu Y, Zhou X, Cao C, Hu X, et al. Bioinformatic prediction of epitopes in the Emy162 antigen of Echinococcus multilocularis. Exp Ther Med 2013; 6:335-340.